This inventor holds 1 USPTO granted patent. Top assignee: Pharmablock Sciences (Nanjing), Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Liu Liu - Innovator in Pharmaceutical Science
Introduction
Liu Liu is a prominent inventor based in Jiangbei New Area, Nanjing, China. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target specific diseases.
Latest Patents
Liu Liu holds a patent for an EZH2 inhibitor and its use in treating EZH2-mediated diseases. The patent describes a compound represented by a specific formula, along with its pharmaceutically acceptable salts, esters, prodrugs, complexes, solvates, hydrates, or isomers. This innovation has the potential to advance therapeutic options for patients suffering from related conditions.
Career Highlights
Liu Liu is currently employed at Pharmablock Sciences (Nanjing), Inc., where he continues to engage in groundbreaking research and development. His work focuses on creating effective pharmaceutical solutions that address critical health issues.
Collaborations
Liu Liu collaborates with various professionals in the field, including his coworker, Hongdao Chen. Their combined expertise contributes to the advancement of innovative treatments and the overall success of their projects.
Conclusion
Liu Liu's contributions to pharmaceutical science, particularly through his patent on EZH2 inhibitors, highlight his role as an influential inventor. His ongoing work at Pharmablock Sciences continues to pave the way for new therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile